Antithrombotic Medication for Cardioembolic Stroke Prevention
Embolism of cardiac origin accounts for about 20% of ischemic strokes. Nonvalvular atrial fibrillation is the most frequent cause of cardioembolic stroke. Approximately 1% of population is affected by atrial fibrillation, and its prevalence is growing with ageing in the modern world. Strokes due to...
Main Authors: | M. Àngels Font, Jerzy Krupinski, Adrià Arboix |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Stroke Research and Treatment |
Online Access: | http://dx.doi.org/10.4061/2011/607852 |
Similar Items
-
Current approaches to antithrombotic therapy in patients with cardioembolic stroke
by: Oleg Ivanovich Vinogradov, et al.
Published: (2013-11-01) -
Updates on Prevention of Cardioembolic Strokes
by: Mehmet Akif Topcuoglu, et al.
Published: (2018-05-01) -
Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review
by: Dániel Tornyos, et al.
Published: (2021-05-01) -
Current perspectives on cardioembolic ischemic stroke in very old patients
by: Arboix A, et al.
Published: (2014-12-01) -
Cardioembolic stroke
by: I. V. Damulin, et al.
Published: (2015-03-01)